OTC Medicines

Select an Issue

Browse OTC Medicines Content

dollar bills on a light blue background

Infographic

OTC Medicines Save the U.S. Healthcare System Money

Every $1 spent on OTC medicines saves the U.S. healthcare system more than $7.

Jun 1, 2020

Homeopathy sign in a store

Submission

Drug Products Labeled as Homeopathic

On behalf of the Consumer Healthcare Products Association, enclosed herein are comments on the 2019 revised draft guidance document as well as FDA’s decision to revoke CPG 400.400.

May 19, 2020

blue coronavirus particles on dark background

Press Releases and Statements

CHPA Statement Regarding Use of Dextromethorphan and COVID-19

There is currently no clinical data indicating that dextromethorphan has a pro-viral effect in people with COVID-19 infection. The study results published in Nature are experimental, preliminary, and not conclusive.

May 6, 2020

long vertical infographic outlining the highlights of OTC monograph reform

Infographic

Over the Counter Medicines Modern Regulation

After more than four decades, we now have a modern OTC Monograph system to unlock gridlock, spur innovation, and better serve consumers.

May 1, 2020

FDA headquarters sign in Washington DC

Press Releases and Statements

Statement Regarding FDA Request to Remove All Ranitidine Products from the Market

OTC manufacturers share FDA’s commitment to providing consumers with products that are safe and effective.

Apr 2, 2020

three quarter view of U.S. capitol building from below

Articles

OTC Monograph Reform As Included in H.R. 748

Mar 27, 2020

blue coronavirus particles on dark background

Press Releases and Statements

CHPA Statement Regarding OTC Measures in COVID-19 Legislation

Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act.

Mar 27, 2020

Video

A Safe Medicine Storage Message from Miss America 2020

Mar 11, 2020

person applying lotion to hands

Submission

Comments to FDA: Transdermal and Topical Delivery Systems

Enclosed are comments on “Transdermal and Topical Delivery Systems - Product Development and Quality Considerations”. CHPA and our member companies marketing external analgesic ingredients have an interest, experience, and expertise in this area and appreciate this opportunity to comment.

Feb 19, 2020

front view of the california state capitol flanked by trees

Press Releases and Statements

CHPA Statement Regarding California’s Upcoming Review of Acetaminophen

Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.

Jan 23, 2020

Filter Results